The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection

Immunology and Cell Biology

Volumn 87, Issue 6, 2009, Pages 457-463

  Davtyan, Tigran K ^a   Hovsepyan, Marine P ^a   Mkhitaryan, Levon M ^a,b   Hakobyan, Gagik S ^b   Brazil, Aiden ^c   Barrett, Lisa ^c,d   Hirsch, Geri ^d   Peltekian, Kevork M ^d   Grant, Michael D ^c  

^a Armenicum Research Centre Yerevan   (Armenia)

^b YEREVAN STATE UNIVERSITY   (Armenia)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

B cell; CD5; Hepatitis c virus; Idiotype; IgG; IgM

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD5 ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN M;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD5; ARMENIA; B-LYMPHOCYTES; CANADA; CELL SEPARATION; CROSS REACTIONS; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 69049113876     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.18     Document Type: Article

References (42)

1. Behn U. Idiotypic networks: toward a renaissance? Immunol Rev 2007; 216: 142-152.
2. Lee W, Cosenza H, Köhler H. Clonal restriction of the immune response to phosphorylcholine. Nature 1974; 247: 55-57.
3. Lötscher M, Amstutz H, Heusser CH, Blaser K. Fine specificity and heavy chain V gene usage of antibodies to the phosphorylcholine hapten. Mol Immunol 1990; 27: 369-378. (Pubitemid 20117006)
4. Augustin A, Cosenza H. Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur J Immunol 1976; 6: 497-501.
5. Cosenza H, Quintáns J, Lefkovits I. Antibody response to phosphorylcholine in vitro. I. Studies on the frequency of precursor cells, average clone size and cellular cooperation. Eur J Immunol 1975; 5: 343-349.
6. Fung J, Köhler H. Late clonal selection and expansion of the TEPC-15 germ-line specificity. J Exp Med 1980; 152: 1262-1273. (Pubitemid 11241627)
7. Kim BS, Benewicz BJ. The lack of compensatory increases of cells producing antiphosphorylcholine antibodies bearing other idiotypes in TEPC-15 idiotype-suppressed inbred and outbred mice. Eur J Immunol 1980; 10: 171-175.
8. Hu L, Rezanka LJ, Mi QS, Lustig A, Taub DD, Longo DL et al. T15-idiotype-negative B cells dominate the phosphocholine binding cells in the preimmune repertoire of T15i knockin mice. J Immunol 2002; 168: 1273-1280. (Pubitemid 34094495)
9. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 125C: 373-389.
10. Vakil M, Briles DE, Kearney JF. Antigen-independent selection of T15 idiotype during B-cell ontogeny in mice. Dev Immunol 1991; 1: 203-212.
11. Bona CA, Goldberg B, Rubinstein LJ. Regulatory idiotopes, parallel sets and internal image of the antigen within the polyfructosan-A48 idiotypic network. Ann Immunol (Paris) 1984; 135C: 107-115. (Pubitemid 14150226)
12. Sela O, El-Roeiy A, Isenberg DA, Kennedy RC, Colaco CB, Pinkhas J et al. A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 1987; 30: 50-55. (Pubitemid 17007260)
13. Abu-Shakra M, Shoenfeld Y. Human anti-DNA idiotype (16/6 idiotype): pathogenic role in autoimmunity. Hum Antibody Hybrid 1990; 10: 1-14. (Pubitemid 20320597)
14. El-Roeiy A, Sela O, Isenberg D, Kennedy RL, Shoenfeld Y. The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide activity. Clin Exp Immunol 1987; 67: 507-515. (Pubitemid 17031791)
15. Mendlovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R et al. Induction of an SLE-like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci 1988; 85: 2260-2264.
16. Shoenfeld Y, Amital-Tepllizki H, Mendlovic S, Blank M, Mozes E, Isenberg DA. The role of the human anti-DNA idiotype 16/6 in autoimmunity. Clin Immunol Immunopathol 1989; 4: 277-287.
17. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994; 8: 1296-1301.
18. Cohen IR. The cognitive paradigm and the immunological homunculus. Immunol Today 1992; 13: 490-494.
19. Muller S, Wang H-T, Kaveri S-V, Chattopadhyay S, Kohler H. Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-specific antibodies. J Immunol 1991; 147: 933-941.
20. Muller S, Wang H, Silverman GJ, Bramlet G, Haigwood N, Kohler H. B-cell abnormalities in AIDS, Stable and clonally-restricted antibody response in HIV-1 infection. Scand J Immunol 1993; 38: 327-334. (Pubitemid 23294773)
21. Wang HT, Muller S, Zolla-Pazner S, Kohler H. 1992. Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity. Eur J Immunol 1992; 22: 1749-1755.
22. Grant M, Whaley M, Mayne A, Hoffmann G, Ansari AA. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques. Immunol Cell Biol 1996; 174: 38-44. (Pubitemid 26151478)
23. Grant M. Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections. J Med Virol 2002; 66: 13-21. (Pubitemid 34183712)
24. Kipps TJ, Robbins BA, Tefferi A, Meisenholder G, Banks PM, Carson DA. CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies. Am J Pathol 1990; 136: 809-816. (Pubitemid 20142317)
25. Köhler H, Müller S, Nara PL. Deceptive imprinting in the immune response against HIV-1. Immunol Today 1994; 15: 475-478. (Pubitemid 24316013)
26. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577.
27. Curry MP, Golden-Mason L, Nolan N, Parfrey NA, Hegarty JE, O'Farrelly C. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection. J Hepatol 2000; 32: 121-125. (Pubitemid 30039456)
28. Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K et al. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 2002; 128: 353-358. (Pubitemid 34534052)
29. Toubi E, Kessel A, Peri R, Shmuel Z, Bamberger E, Sabo E et al. Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment. J Virol 2004; 78: 11379-11384. (Pubitemid 39299679)
30. Curry MP, Golden-Mason L, Doherty DG, Deignan T, Norris S, Duffy M et al. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 2003; 38: 642-650. (Pubitemid 36560650)
31. Freedman AS. Immunobiology of chronic lymphocytic leukemia. Hematol Oncol Clin North Am 1990; 4: 405-429.
32. O'Garra A, Howard M. IL-10 production by CD5 B cells. Ann NY Acad Sci 1992; 651: 182-199.
33. Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 2000; 118: 655-660. (Pubitemid 30171614)
34. Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and antiinflammatory effect. Hepatology 2003; 38: 859-868. (Pubitemid 37221669)
35. Brady MT, MacDonald AJ, Rowan G, Mills KH. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003; 33: 3448-3457.
36. Aborsangaya KB, Dembinski I, Khatkar S, Alphonse MP, Nickerson P, Rempel JD. Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology 2007; 45: 623-630. (Pubitemid 46450613)
37. Barrett LB, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K et al. Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals. BMC Immunol 2008; 9: 28-44. (Pubitemid 352003722)
38. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006; 12: 1301-1309. (Pubitemid 44706933)
39. Kaplan DE, Sugimoto K, Newton K, Valiga ME, Ikeda F, Aytaman A et al. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 2007; 132: 654-666. (Pubitemid 46274664)
40. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348: 1347-1351. (Pubitemid 26383775)
41. Scognamiglio P, Accapezzato D, Casciaro MA, Cacciani A, Artini M, Bruno G et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 1999; 162: 6681-6689. (Pubitemid 29309393)
42. Al-Sherbiny M, Osman A, Mohamed N, Shata MT, Abdel-Aziz F, Abdel-Hamid M et al. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 2005; 73: 44-49. (Pubitemid 41278744)